IMATINIB FORMULATIONS

Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BHISE, RAHUL, MALLADI, MADHUSUDAN, BISWAS, MOUMITA, KOTA, RAMESH, KONATHAM, SURESH, VURE, PRASAD
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BHISE, RAHUL
MALLADI, MADHUSUDAN
BISWAS, MOUMITA
KOTA, RAMESH
KONATHAM, SURESH
VURE, PRASAD
description Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient. L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013008253A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013008253A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013008253A23</originalsourceid><addsrcrecordid>eNrjZBD19HUM8fTzdFJw8w_yDfUBcvz9gnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobGBgYWRqbGjkTFxqgAjIR_u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMATINIB FORMULATIONS</title><source>esp@cenet</source><creator>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</creator><creatorcontrib>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</creatorcontrib><description>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient. L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130117&amp;DB=EPODOC&amp;CC=WO&amp;NR=2013008253A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130117&amp;DB=EPODOC&amp;CC=WO&amp;NR=2013008253A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BHISE, RAHUL</creatorcontrib><creatorcontrib>MALLADI, MADHUSUDAN</creatorcontrib><creatorcontrib>BISWAS, MOUMITA</creatorcontrib><creatorcontrib>KOTA, RAMESH</creatorcontrib><creatorcontrib>KONATHAM, SURESH</creatorcontrib><creatorcontrib>VURE, PRASAD</creatorcontrib><title>IMATINIB FORMULATIONS</title><description>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient. L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD19HUM8fTzdFJw8w_yDfUBcvz9gnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobGBgYWRqbGjkTFxqgAjIR_u</recordid><startdate>20130117</startdate><enddate>20130117</enddate><creator>BHISE, RAHUL</creator><creator>MALLADI, MADHUSUDAN</creator><creator>BISWAS, MOUMITA</creator><creator>KOTA, RAMESH</creator><creator>KONATHAM, SURESH</creator><creator>VURE, PRASAD</creator><scope>EVB</scope></search><sort><creationdate>20130117</creationdate><title>IMATINIB FORMULATIONS</title><author>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013008253A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BHISE, RAHUL</creatorcontrib><creatorcontrib>MALLADI, MADHUSUDAN</creatorcontrib><creatorcontrib>BISWAS, MOUMITA</creatorcontrib><creatorcontrib>KOTA, RAMESH</creatorcontrib><creatorcontrib>KONATHAM, SURESH</creatorcontrib><creatorcontrib>VURE, PRASAD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BHISE, RAHUL</au><au>MALLADI, MADHUSUDAN</au><au>BISWAS, MOUMITA</au><au>KOTA, RAMESH</au><au>KONATHAM, SURESH</au><au>VURE, PRASAD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMATINIB FORMULATIONS</title><date>2013-01-17</date><risdate>2013</risdate><abstract>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient. L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2013008253A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title IMATINIB FORMULATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BHISE,%20RAHUL&rft.date=2013-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013008253A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true